TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bioxyne Limited ( (AU:BXN) ) has issued an update.
Bioxyne Limited reported a significant financial turnaround for the year ending June 30, 2025, with a 215% increase in revenue from ordinary activities and a net profit of $4.9 million, compared to a substantial loss in the previous year. This financial improvement highlights Bioxyne’s strengthened market position and operational efficiency, although no dividends were proposed, and the company disposed of a dormant entity, Always Pure Organics Japan KK.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology sector, focusing on the development and commercialization of health and wellness products. The company primarily offers probiotic and immune health products, targeting both domestic and international markets.
Average Trading Volume: 5,116,791
Technical Sentiment Signal: Buy
Current Market Cap: A$126M
Learn more about BXN stock on TipRanks’ Stock Analysis page.